Metabolism Books
John Wiley and Sons Ltd Primer on the Metabolic Bone Diseases and
Book SynopsisThe authoritative reference to bone diseases and disorders of mineral metabolism, revised and updated Now in its ninth edition,The Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolismoffers anupdated and comprehensive guide tobone and mineral health. Since it was first published 30 years ago, the Primer has become the leading reference on the topic. With contributions from noted experts, the text explores basic biological factors of healthy development and disease states and makes the information accessible for clinical interventions. The ninth edition provides concise coverage of the widest possible spectrum of metabolic bone diseases and disorders of mineral metabolism. The new edition of this invaluable reference expands coverage and includes the most recent developments in the field that help to strengthen its usefulness and ensure that thePrimer on the Metabolic Bone Diseases and Disorders of Mineral Metabolismmaintains its place as the pre-eminent referencTable of ContentsContributors xi Preface to the Ninth Edition of the Primer:John P. Bilezikian xxiv About ASBMR xxv President’s Preface Michael J. Econs xxvi About the Companion Website xxvii Section I Molecular and Cellular Determinants of Bone Structure and Function 1Section Editor Karen Lyons 1 Early Skeletal Morphogenesis in Embryonic Development 3Yingzi Yang 2 Endochondral Ossification 12Courtney M. Karner and Matthew J. Hilton 3 Local and Circulating Osteoprogenitor Cells and Lineages 20Naomi Dirckx and Christa Maes 4 Osteoblasts Function, Development, and Regulation 31Elizabeth W. Bradley, Jennifer J. Westendorf, Andre J. van Wijnen, and Amel Dudakovic 5 Osteocytes 38Lynda F. Bonewald 6 Osteoclast Biology and Bone Resorption 46Hiroshi Takayanagi 7 Signal Transduction Cascades Controlling Osteoblast Differentiation 54David J.J. de Gorter, Gonzalo Sánchez‐Duffhues, and Peter ten Dijke 8 The TGF‐β Superfamily in Bone Formation and Maintenance 60Ce Shi and Yuji Mishina 9 Recent Developments in Understanding the Role of Wnt Signaling in Skeletal Development and Disease 68Zhendong A. Zhong, Nicole J. Ethen, and Bart O. Williams 10 Mechanotransduction in Bone Formation and Maintenance 75Whitney A. Bullock, Lilian I. Plotkin, Alexander G. Robling, and Fredrick M. Pavalko 11 The Composition of Bone 84Adele L. Boskey and Pamela G. Robey 12 Assessment of Bone Mass, Structure, and Quality in Rodents 93Jeffry S. Nyman and Deepak Vashishth 13 Skeletal Healing Cellular and Molecular Determinants 101Alayna E. Loiselle and Michael J. Zuscik 14 Biomechanics of Fracture Healing 108Elise F. Morgan, Amira I. Hussein, and Thomas A. Einhorn Section II Skeletal Physiology 115Section Editor Ego Seeman 15 Human Fetal and Neonatal Bone Development 117Tao Yang, Monica Grover, Kyu Sang Joeng, and Brendan Lee 16 Skeletal Growth a Major Determinant of Bone’s Structural Diversity in Women and Men 123Ego Seeman 17 Racial Differences in the Acquisition and Age‐related Loss of Bone Strength 131Shane A. Norris, Marcella D. Walker, Kate Ward, Lisa K. Micklesfield, and John M. Pettifor 18 Calcium, Vitamin D, and Other Nutrients During Growth 135Tania Winzenberg and Graeme Jones 19 Mechanical Loading and the Developing Skeleton 141Mark R. Forwood 20 Pregnancy and Lactation 147Christopher S. Kovacs and Henry M. Kronenberg 21 Menopause and Age‐related Bone Loss 155Carlos M. Isales and Ego Seeman Section III Mineral Homeostasis 163Section Editors David Goltzman and Harald Jüppner 22 Regulation of Calcium Homeostasis 165Line Vautour and David Goltzman 23 Magnesium Homeostasis 173Aliya Aziz Khan, Asiya Sbayi, and Karl Peter Schlingmann 24 Fetal Calcium Metabolism 179Christopher S. Kovacs 25 FGF23 and the Regulation of Phosphorus Metabolism 187Kenneth E. White and Michael J. Econs 26 Gonadal Steroids 194Stavros C. Manolagas and Maria Schuller Almeida 27 Parathyroid Hormone 205Thomas J. Gardella, Robert A. Nissenson, and Harald Jüppner 28 Parathyroid Hormone‐Related Protein 212John J. Wysolmerski and T. John Martin 29 Calcium‐Sensing Receptor 221Geoffrey N. Hendy 30 Vitamin D Production, Metabolism, Action, and Clinical Requirements 230Daniel D. Bikle, John S. Adams, and Sylvia Christakos Section IV Investigation of Metabolic Bone Diseases 241Section Editors Douglas C. Bauer and Klaus Engelke 31 Techniques of Bone Mass Measurement in Children with Risk Factors for Osteoporosis 243Nicola J. Crabtree and Leanne M. Ward 32 Standard Techniques of Bone Mass Measurement in Adults 252E. Michael Lewiecki, Paul D. Miller, and Nelson B. Watts 33 Advanced Techniques of Bone Mass Measurements and Strength in Adults 260Kyle K. Nishiyama, Enrico Dall’Ara, and Klaus Engelke 34 Magnetic Resonance Imaging of Bone 272Sharmila Majumdar 35 Trabecular Bone Score 277Barbara C. Silva and William D. Leslie 36 Reference Point Indentation 287Adolfo Diez‐Perez and Joshua N. Farr 37 Biochemical Markers of Bone Turnover in Osteoporosis 293Pawel Szulc, Douglas C. Bauer, and Richard Eastell 38 Scintigraphy and PET in Metabolic Bone Disease 302Lorenzo Nardo, Paola A. Erba, and Benjamin L. Franc 39 Bone Histomorphometry in Clinical Practice 310Robert R. Recker and Carolina Aguiar Moreira 40 Diagnosis and Classification of Vertebral Fracture 319James F. Griffith and Harry K. Genant 41 FRAX Assessment of Fracture Risk 331John A. Kanis, Eugene V. McCloskey, Nicholas C. Harvey, and William D. Leslie Section V Genetics of Bone 341Section Editor Rajesh V. Thakker 42 Introduction to Genetics 343Paul J. Newey, Michael P. Whyte, and Rajesh V. Thakker 43 Animal Models Genetic Manipulation 351Karen Lyons 44 Animal Models Allelic Determinants for Bone Mineral Density 359J. H. Duncan Bassett, Graham R. Williams, and Robert D. Blank 45 Transcriptional Profiling for Genetic Assessment 367Aimy Sebastian and Gabriela G. Loots 46 Approaches to Genetic Testing 373Christina Jacobsen, Yiping Shen, and Ingrid A. Holm 47 Human Genome‐Wide Association Studies 378Douglas P. Kiel, Emma L. Duncan, and Fernando Rivadeneira 48 Translational Genetics of Osteoporosis From Population Association to Individualized Assessment 385Bich Tran, Jacqueline R. Center, and Tuan V. Nguyen Section VI Osteoporosis 393Section Editors Paul D. Miller, Socrates E. Papapoulos, and Michael R. McClung 49 Osteoporosis an Overview 395Michael R. McClung, Paul D. Miller, and Socrates E. Papapoulos 50 The Epidemiology of Osteoporotic Fractures 398Nicholas C. Harvey, Elizabeth M. Curtis, Elaine M. Dennison, and Cyrus Cooper 51 Fracture Liaison Service 405Piet Geusens, John A. Eisman, Andrea Singer, and Joop van den Bergh 52 Sex Steroids and the Pathogenesis of Osteoporosis 412Matthew T. Drake and Sundeep Khosla 53 Juvenile Osteoporosis 419Francis H. Glorieux and Craig Munns 54 Transplantation Osteoporosis 424Peter R. Ebeling 55 Premenopausal Osteoporosis 436Adi Cohen and Elizabeth Shane 56 Osteoporosis in Men 443Eric S. Orwoll and Robert A. Adler 57 Bone Stress Injuries 450Stuart J. Warden and David B. Burr 58 Inflammation‐Induced Bone Loss in the Rheumatic Diseases 459 Ellen M. Gravallese and Steven R. Goldring 59 Glucocorticoid‐Induced Osteoporosis 467Kenneth Saag and Robert A. Adler 60 Human Immunodeficiency Virus and Bone 474Michael T. Yin and Todd T. Brown 61 Effects on the Skeleton from Medications Used to Treat Nonskeletal Disorders 482Nelson B. Watts 62 Diabetes and Fracture Risk 487Serge Ferrari, Nicola Napoli, and Ann Schwartz 63 Obesity and Skeletal Health 492Juliet Compston 64 Sarcopenia and Osteoporosis 498Gustavo Duque and Neil Binkley 65 Management of Osteoporosis in Patients with Chronic Kidney Disease 505Paul D. Miller 66 Other Secondary Causes of Osteoporosis 510Neveen A. T. Hamdy and Natasha M. Appelman‐Dijkstra 67 Exercise for Osteoporotic Fracture Prevention and Management 517Robin M. Daly and Lora Giangregorio 68 Prevention of Falls 526Heike A. Bischoff‐Ferrari 69 Nutritional Support for Osteoporosis 534Connie M. Weaver, Bess Dawson‐Hughes, Rene Rizzoli, and Robert P. Heaney 70 Estrogens, Selective Estrogen Receptor Modulators, and Tissue‐Selective Estrogen Complex 541Tobias J. de Villiers 71 Bisphosphonates for Postmenopausal Osteoporosis 545Andrea Giusti and Socrates E. Papapoulos 72 Denosumab 553Aline Granja Costa, E. Michael Lewiecki, and John P. Bilezikian 73 Parathyroid Hormone and Abaloparatide Treatment for Osteoporosis 559Felicia Cosman and Susan L. Greenspan 74 Combination Anabolic and Antiresorptive Therapy for Osteoporosis 567Joy N. Tsai and Benjamin Z. Leder 75 Strontium Ranelate and Calcitonin 573Leonardo Bandeira and E. Michael Lewiecki 76 Adverse Effects of Drugs for Osteoporosis 579Bo Abrahamsen and Daniel Prieto‐Alhambra 77 Orthopedic Principles of Fracture Management 588Manoj Ramachandran and David G. Little 78 Adherence to Osteoporosis Therapies 593Stuart L. Silverman and Deborah T. Gold 79 Cost‐Effectiveness of Osteoporosis Treatment 597Anna N.A. Tosteson 80 Future Therapies 603Michael R. McClung Section VII Metabolic Bone Diseases 611Section Editors Suzanne M. Jan de Beur and Peter R. Ebeling 81 Approach to Parathyroid Disorders 613John P. Bilezikian 82 Primary Hyperparathyroidism 619Shonni J. Silverberg, Francisco Bandeira, Jianmin Liu, Claudio Marcocci, and Marcella D. Walker 83 Familial States of Primary Hyperparathyroidism 629Andrew Arnold, Sunita K. Agarwal, and Rajesh V. Thakker 84 Non‐Parathyroid Hypercalcemia 639Mara J. Horwitz 85 Hypocalcemia Definition, Etiology, Pathogenesis, Diagnosis, and Management 646Anne L. Schafer and Dolores M. Shoback 86 Hypoparathyroidism 654Tamara Vokes, Mishaela R. Rubin, Karen K. Winer, Michael Mannstadt, Natalie E. Cusano, Harald Jüppner, and John P. Bilezikian 87 Pseudohypoparathyroidism 661Agnès Linglart, Michael A. Levine, and Harald Jüppner 88 Disorders of Phosphate Homeostasis 674Mary D. Ruppe and Suzanne M. Jan de Beur 89 Rickets and Osteomalacia 684Michaël R. Laurent, Nathalie Bravenboer, Natasja M. Van Schoor, Roger Bouillon, John M. Pettifor, and Paul Lips 90 Pathophysiology and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder 695Mark R. Hanudel, Sharon M. Moe, and Isidro B. Salusky 91 Disorders of Mineral Metabolism in Childhood 705Thomas O. Carpenter and Nina S. Ma 92 Paget Disease of Bone 713Julia F. Charles, Ethel S. Siris, and G. David Roodman 93 Epidemiology, Diagnosis, Evaluation, and Treatment of Nephrolithiasis 721Murray J. Favus and David A. Bushinsky 94 Immobilization and Burns Other Conditions Associated with Osteoporosis 730William A. Bauman, Christopher Cardozo, and Gordon L. Klein Section VIII Cancer and Bone 737Section Editors Theresa Guise and G. David Roodman 95 Mechanisms of Osteolytic and Osteoblastic Skeletal Lesions 739G. David Roodman and Theresa Guise 96 Clinical and Preclinical Imaging in Osseous Metastatic Disease 743Siyang Leng and Suzanne Lentzsch 97 Metastatic Tumors and Bone 752Julie A. Sterling and Rachelle W. Johnson 98 Myeloma Bone Disease and Other Hematological Malignancies 760Claire M. Edwards and Rebecca Silbermann 99 Osteogenic Osteosarcoma 768Yangjin Bae, Huan‐Chang Zeng, Linchao Lu, Lisa L. Wang, and Brendan Lee 100 Skeletal Complications of Breast and Prostate Cancer Therapies 775Catherine Van Poznak and Pamela Taxel 101 Bone Cancer and Pain 781Denis Clohisy and Lauren M. MacCormick 102 Radiotherapy‐Induced Osteoporosis 788Laura E. Wright 103 Skeletal Complications of Childhood Cancer 793Manasa Mantravadi and Linda A. DiMeglio 104 Medical Prevention and Treatment of Bone Metastases 799Catherine Handforth, Stella D’Oronzo, and Janet Brown 105 Radiotherapy of Skeletal Metastases 809Srinivas Raman, K. Liang Zeng, Oliver Sartor, Edward Chow, and Øyvind S. Bruland 106 Concepts and Surgical Treatment of Metastatic Bone Disease 816Kristy Weber and Scott L. Kominsky Section IX Sclerosing and Dysplastic Bone Diseases 823Section Editor Michael P. Whyte 107 Sclerosing Bone Disorders 825Michael P. Whyte 108 Fibrous Dysplasia 839Michael T. Collins, Alison M. Boyce, and Mara Riminucci 109 The Osteochondrodysplasias 848Fabiana Csukasi and Deborah Krakow 110 Ischemic and Infiltrative Disorders of Bone 853Michael P. Whyte 111 Tumoral Calcinosis – Dermatomyositis 861Nicholas J. Shaw 112 Genetic Disorders of Heterotopic Ossification: Fibrodysplasia Ossificans Progressiva and Progressive OsseousHeteroplasia 865Frederick S. Kaplan, Robert J. Pignolo, Mona Al Mukaddam, and Eileen M. Shore 113 Osteogenesis Imperfecta 871Joan C. Marini 114 Fibrillinopathies Skeletal Manifestations of Marfan Syndrome and Marfan‐Related Conditions 878Gary S. Gottesman and Michael P. Whyte 115 Hypophosphatasia and Other Enzyme Deficiencies Affecting the Skeleton 886Michael P. Whyte Section X Oral and Maxillofacial Biology and Pathology 891Section Editor Laurie McCauley 116 Craniofacial Morphogenesis 893Erin Ealba Bumann and Vesa Kaartinen 117 Development and Structure of Teeth and Periodontal Teeth 901Petros Papagerakis and Thimios Mitsiadis 118 Genetic Craniofacial Disorders Affecting the Dentition 911Yong‐Hee Patricia Chun, Paul H. Krebsbach, and James P. Simmer 119 Pathology of the Hard Tissues of the Jaws 918Paul C. Edwards 120 Osteonecrosis of the Jaw 927Sotirios Tetradis, Laurie McCauley, and Tara Aghaloo 121 Alveolar Bone Homeostasis in Health and Disease 933Chad M. Novince and Keith L. Kirkwood 122 Oral Manifestations of Metabolic Bone Diseases 941Erica L. Scheller, Charles Hildebolt, and Roberto Civitelli 123 Dental Implants and Osseous Healing in the Oral Cavity 949Takashi Matsuura and Junro Yamashita Section XI Integrative Physiology of the Skeleton 957Section Editors Mone Zaidi and Clifford J. Rosen 124 Integrative Physiology of the Skeleton 959Clifford J. Rosen and Mone Zaidi 125 The Hematopoietic Niche and Bone 966Stavroula Kousteni, Benjamin J. Frisch, Marta Galan‐Diez, and Laura M. Calvi 126 Adipocytes and Bone 974Clarissa S. Craft, Natalie K. Wee, and Erica L. Scheller 127 The Vasculature and Bone 983Marie Hélène Lafage‐Proust and Bernard Roche 128 Immunobiology and Bone 992Roberto Pacifici and M. Neale Weitzmann 129 Cellular Bioenergetics of Bone 1004Wen‐Chih Lee and Fanxin Long 130 Endocrine Bioenergetics of Bone 1012Patricia F. Ducy and Gerard Karsenty 131 Central Neuronal Control of Bone Remodeling 1020Hiroki Ochi, Paul Baldock, and Shu Takeda 132 Peripheral Neuronal Control of Bone Remodeling 1028Katherine J. Motyl and Mary F. Barbe 133 The Pituitary–Bone Axis in Health and Disease 1037Mone Zaidi, Tony Yuen, Wahid Abu‐Amer, Peng Liu, Terry F. Davies, Maria I. New, Harry C. Blair, Alberta Zallone, Clifford J. Rosen, and Li Sun 134 Neuropsychiatric Disorders and the Skeleton 1047Madhusmita Misra and Anne Klibanski 135 Interactions Between Muscle and Bone 1055Marco Brotto Index 1063
£129.15
John Wiley and Sons Ltd Endocrine and Metabolic Medical Emergencies
Book SynopsisThe Essential Guide to Recognizing and Treating Acute Endocrine and Metabolic Illness Endocrinology covers some of the most common conditions and serious public health challenges facing medicine today, and endocrine and metabolic emergencies constitute a large proportion of the clinical workload. Endocrine and Metabolic Medical Emergencies: A Clinician's Guide provides a singular reference to help endocrinologists, acute and general medicine clinicians, hospitalists and critical care physicians, and general practitioners recognize the symptoms of endocrine emergencies and provide the highest standards of care. Already the definitive and most comprehensive guide to endocrine emergency care, this new second edition: provides acute care guidance for a range of both common and unusual endocrine emergencies; details the effects of acute medical and critical illness on metabolic and endocrine systems, and their impacts on endocrine investigations; discusses special paTable of ContentsNotes on Contributors x Foreword xv Preface xvi List of Abbreviations xviii Part I General Aspects of AcuteMedical Emergencies 1 Introduction: AcuteMedical Care: A Crisis with Solutions 3GlennMatfin 1 Early Management of AcuteMedical Emergencies 10Paul J. Frost and Matt P.Wise Part II General Endocrine and Metabolic Aspects of Acute and Critical Illness 21 Introduction: Endocrine Testing and Responses in Acute and Critical Illness 23David B. Sacks 2 Endocrine Testing in Acute and Critical Illness 28Reza Morovat 3 Endocrine Responses to Critical Illness: Novel Insights and Therapeutic Implications 60Jan Gunst, Eva Boonen, and Greet Van den Berghe Part III Special Populations 83 4 Endocrine and Metabolic Emergencies in Pregnancy 85Anita Banerjee and CatherineWilliamson 5 Endocrine and Metabolic Emergencies in Inherited Metabolic Diseases: Acute Presentations in Adulthood 98Elaine Murphy and Robin H. Lachmann 6 Endocrine and Metabolic Emergencies in Transitional Care 110Mabel Yau andMark A. Sperling 7Emergency Perioperative Diabetes and Endocrine Management 129Glenn Matfin, Kate Evans, and Ketan Dhatariya 8 Endocrine and Metabolic Emergencies in HIV/AIDS 151Katherine Samaras 9 Endocrine and Metabolic Emergencies in Late-Effects Patients: Consequences of Cancer Therapy 160Helena Gleeson and Andrew Toogood 10 Endocrine and Metabolic Emergencies in Transplantation 171Robert A. Wermers and Pankaj Shah 11 Endocrine and Metabolic Changes with Aging: Endocrin-Aging: Recognizing and Managing Care in Older Frail Persons 182Angela M. Abbatecola and John E.Morley Part IV Pituitary Disorders 195 Introduction: Emergency Management of Pituitary Disorders 197Edward R. Laws and Ursula B. Kaiser 12 Hypopituitarism 203Nicholas A. Tritos and Anne Klibanski 13 Pituitary Apoplexy 218Claire Briet and Philippe Chanson 14 Macroprolactinomas 231Mark E. Molitch Part V Thyroid Disorders 243 Introduction: Emergency Management of Thyroid Disorders 245Hossein Gharib 15 Myxedema Coma 252Natasha Kasid and James V. Hennessey 16 Life-Threatening Thyrotoxicosis: Thyroid Storm and Adverse Effects of Antithyroid Drugs 262Alicia L.Warnock, David S. Cooper, and Henry B. Burch 17 Amiodarone-Induced Thyrotoxicosis 284Fausto Bogazzi, Luca Tomisti, Luigi Bartalena, and Enio Martino 18 Thyrotoxic Periodic Paralysis 296Mark Vanderpump 19 Sight-Threatening Graves’Orbitopathy 305Rebecca S. Bahn and James A. Garrity Part VI Adrenal Disorders 313 Introduction: Emergency Management of Adrenal Disorders 315Anand Vaidya 20 Acute Adrenal Insufficiency 321Glenn Matfin 21 Acute Medical Aspects Related to Florid Cushing’s Syndrome 345Krystallenia I. Alexandraki and Ashley B. Grossman 22 Endocrine Hypertensive Emergencies 355Graeme Eisenhofer, Andrzej Januszewicz, Christina Pamporaki, and Jacques W. M. Lenders Part VII Calcium, Phosphate, and Metabolic Bone Diseases 375 Introduction: Emergency Management of Calcium, Phosphate, and Metabolic Bone Diseases 377John P. Bilezikian 23 Hypocalcemia 380Glenn Matfin 24 Hypercalcemia 400Glenn Matfin 25 Acute Medical Aspects Related to Phosphate Disorders 422Anda R. Gonciulea and Suzanne M. Jan de Beur 26 Acute Medical Aspects Related to Osteoporosis and Its Therapy 433Dima L. Diab and Nelson B.Watts 27 Acute Medical Aspects Related to Paget’s Disease of Bone 447Ethel S. Siris and Dorothy A. Fink 28 Acute Medical Aspects Related to Kidney Stones 454Hasan Fattah and David S. Goldfarb Part VIII Neuroendocrine Tumors 465 Introduction: Emergency Management of Neuroendocrine Tumors 467Kjell Oberg 29 Acute Endocrine and Metabolic Emergencies Related to Neuroendocrine Tumors 472Gregory Kaltsas, Krystallenia I. Alexandraki, and Ashley B. Grossman Part IX Glucose Disorders 485 Introduction: Emergency Management of Glucose Disorders 487Gerry Rayman 30 Management of Diabetes and/or Hyperglycemia in Non-Critical Care Hospital Settings 491Rodolfo J. Galindo and Guillermo E. Umpierrez 31 Hypoglycemia 506Elizabeth M. Lamos, Lisa M. Younk, and Stephen N. Davis 32 Severe Hyperglycemia, Diabetic Ketoacidosis, and Hyperglycemic Hyperosmolar State 531Ketan Dhatariya and GlennMatfin 33 Short-Term Intensive Insulin Therapy in Patients with Newly Presenting Type Diabetes 548Wen Xu, David Owens, and JianpingWeng 34 Management of Concentrated Insulins in Acute Care Settings 560Nuha El Sayed, Megan J. Ritter, and Alissa R. Segal 35 Management of Insulin Pumps in Hospitalized Patients 571Bithika M. Thompson, Patricia A. Mackey, and Curtiss B. Cook 36 Management of Diabetes and/or Hyperglycemia during Enteral and Parenteral Nutrition 584Aidar R. Gosmanov and Niyaz R. Gosmanov 37 Management of Diabetes and/or Hyperglycemia in Hospitalized Patients with Renal Insufficiency 598Glenn Matfin 38 Management of Glucocorticoid-Induced Diabetes and/or Hyperglycemia 616Han Na Kim and NestorasMathioudakis 39 Management of Diabetes and/or Hyperglycemia in Acute Coronary Syndrome, Acute Stroke, and Acute Heart Failure 632Miles Fisher 40 Acute Diabetic Foot 648Glenn Matfin Part X Sodium Disorders 673 Introduction: Emergency Management of Sodium Disorders 675Richard H. Sterns 41 Emergency Management of Acute and Chronic Hyponatremia 679Joseph G. Verbalis 42 Emergency Management of Acute and Chronic Hypernatremia 700Aoife Garrahy and Christopher Thompson Part XI Obesity and Clinical Lipidology 717 Introduction: Emergency Management Related to Obesity and Clinical Lipidology 719Robert H. Eckel 43 Acute Emergencies Related to Bariatric Surgery 723Michael A. Via and Jeffrey I. Mechanick 44 Chylomicronemia Syndrome: Very Severe Hypertriglyceridemia and Acute Pancreatitis 742Anthony S. Wierzbicki 45 Statin-Related Myopathy and Rhabdomyolysis 760Connie B. Newman and Jonathan A. Tobert Index 775
£144.85
John Wiley and Sons Ltd Bone Marrow Pathology Fifth Edition
Book SynopsisTable of ContentsPreface to the fifth edition vi Acknowledgements vii Abbreviations viii 1 The normal bone marrow 1 2 Special techniques applicable to bone marrow diagnosis 61 3 Infection and reactive changes 109 4 Acute myeloid leukaemia mixed phenotype acute leukaemia the myelodysplastic syndromes and histiocytic neoplasms 185 5 Myeloproliferative and myelodysplastic/myeloproliferative neoplasms and related conditions 267 6 Lymphoproliferative disorders 346 7 Plasma cell neoplasms 487 8 Disorders of erythropoiesis granulopoiesis and thrombopoiesis 537 9 Miscellaneous disorders 585 10 Metastatic and non‐haemopoietic tumours 645 11 Diseases of bone 685 Appendix 699 Index 709
£147.20
John Wiley and Sons Ltd Textbook of Diabetes
Book SynopsisTextbook of Diabetes Classic textbook providing diabetologists and endocrinologists with illustrated and clinically focused content on diabetes Now in its sixth edition, the Textbook of Diabetes has established itself as the modern, international guide to diabetes. Sensibly organized and easy to navigate, with exceptional illustrations, the textbook hosts an unrivalled blend of clinical and scientific content. Written by highly experienced editors and international contributors all of whom have provided insight on new developments in diabetes care. These include the most recent guidelines from the European Association for the Study of Diabetes (EASD), the American Diabetes Association (ADA), Diabetes UK, and the National Institute for Health and Care Excellence (NICE) and information on the latest treatment modalities used around the world. The textbook includes free access to the Wiley Digital Edition which provides easy-to-use searching across the book, the full reference list with web links, illustrations and photographs, and post-publication updates. Sample topics covered in Textbook of Diabetes include: Diabetes in its historical and social context, covering the history of diabetes, past classification and diagnosis of diabetes and the global burden of diabetes Normal physiology, covering glucose homeostasis, islet function and insulin secretion, and glucagon in islet and metabolic regulation Pathogenesis of diabetes, covering genetics of diabetes and obesity, autoimmune type 1 diabetes and other disorders with type 1 diabetes phenotype Other types of diabetes, covering endocrine disorders that cause diabetes, pancreatic diseases and diabetes and drug-induced diabetes Beautifully illustrated with a clinical focus, Textbook of Diabetes provides endocrinologists and diabetologists, both consultants/specialists and those in training, with a fresh and comprehensive clinical resource to consult time and time again. The text is also of value to specialist diabetes nurses and researchers in the field.Table of ContentsList of Contributors, viii Preface, xv List of Abbreviations, xvi Part 1 Diabetes in its Historical and Social Context 1 The History of Diabetes Mellitus, 3Robert B. Tattersall and David R. Matthews 2 Classification and Diagnosis of Diabetes, 22Ambady Ramachandran, Chamukuttan Snehalatha, Arun Raghavan, and Arun Nanditha 3 The Global Burden of Diabetes, 28Jessica L. Harding, Mary Beth Weber, and Jonathan E. Shaw 4 Epidemiology of Type 1 Diabetes, 41Lars C. Stene and Jaakko Tuomilehto 5 Epidemiology of Type 2 Diabetes, 55Ronald C.W. Ma and Peter C.Y. Tong Part 2 Normal Physiology 6 Overview of Glucose Metabolism, 77Richard I.G. Holt 7 Islet Function and Insulin Secretion, 84Peter M. Jones and Shanta J. Persaud 8 Glucagon in Islet and Metabolic Regulation, 99Jonathan E. Campbell and David A. D'Alessio 9 Mechanism of Insulin Action, 111Morris F. White 10 Central Control of Glucose Homeostasis, 128Kimberly M. Alonge, Kendra L. Francis, Nicole E. Richardson, and Michael W. Schwartz 11 Control of Body Weight: How and Why Do We Gain Weight Easier Than We Lose It?, 142Janine Makaronidis and Rachel L. Batterham Part 3 Pathogenesis of Diabetes 12 The Genetics of Diabetes, 157Rashmi B. Prasad 13 Genetics of Obesity, 197I. Sadaf Farooqi 14 Autoimmune Type 1 Diabetes, 203Omar Akel and Ake Lernmark 15 Other Disorders with Type 1 Diabetes and Atypical Phenotypes, 216Alice P.S. Kong, Elaine Y.K. Chow, Andrea O.Y. Luk, and Juliana C.N. Chan 16 Abnormalities of Insulin Secretion and β-Cell Defects in Type 2 Diabetes, 225Stefano Del Prato, Cristina Bianchi, and Giuseppe Daniele 17 Insulin Resistance in Type 2 Diabetes, 238Michael Roden, Kitt Falk Petersen, and Gerald I. Shulman 18 Obesity and Diabetes, 250Nick Finer 19 The Microbiome and Diabetes, 261Amanda J. Cox, Nicholas P. West, and Allan W. Cripps Part 4 Other Types of Diabetes 20 Monogenic Causes of Diabetes, 275Brittany L. Resnick, Maggie H. Shepherd, and Andrew T. Hattersley 21 Drug-Induced Diabetes, 295Charles D. Ponte and Devra K. Dang 22 Diabetes in Hypersecreting Endocrine Disorders, 304Allan A. Vaag, Neil A. Hanley, and Caroline M. Kistorp 23 Pancreatic Disease and Diabetes, 319Ranjit Unnikrishnan and Viswanathan Mohan 24 Clinical Presentations of Diabetes, 330Ee Lin Lim and Roy Taylor Part 5 Managing the Person with Diabetes 25 The Aims of Diabetes Care, 343Katharine D. Barnard-Kelly and Richard I.G. Holt 26 Education to Empower the Person with Diabetes, 354Ingrid Willaing and Michael Vallis 27 Dietary Management of Diabetes, 368Nicola Guess 28 Physical Activities and Diabetes, 382Emma J. Cockcroft and Robert C. Andrews 29 Monitoring Diabetes, 404Emma English 30 Biomarkers and Precision Medicine in Diabetes, 414Sok Cin Tye, Michele Provenzano, and Hiddo J.L. Heerspink Part 6 Treatment of Diabetes 31 Insulin and Insulin Treatment, 431Roman Vangoitsenhoven, Parth Narendran, and Chantal Mathieu 32 New Technologies for Glucose Monitoring, 444Thomas Danne and Olga Kordonouri 33 New Technologies for Insulin Administration, 459Hannah Forde and Pratik Choudhary 34 Whole Pancreas and Islet Cell Transplantation, 473Braulio A. Marfil-Garza, Peter A. Senior, and A.M. James Shapiro 35 Oral Glucose-Lowering Agents, 492Clifford J. Bailey and Andrew J. Krentz 36 Non-insulin Parenteral Therapies, 520Tina Vilsboll, Mikkel Christensen, Andreas Andersen, and Filip K. Knop 37 How to Use Type 2 Diabetes Treatments in Clinical Practice, 534Thomas Karagiannis, Aris Liakos, and Apostolos Tsapas 38 Weight Management and Metabolic Surgery, 551Alexis Sudlow, Dimitri J. Pournaras, and Carel W. le Roux 39 In-Hospital Treatment and Surgery in People with Diabetes, 559Ketan Dhatariya, Philip Newland-Jones, and Mayank Patel 40 Hypoglycaemia in Diabetes, 579Ahmed Iqbal, Elaine Y.K. Chow, Timothy W. Jones, and Simon R. Heller 41 Acute Metabolic Complications of Diabetes: Diabetic Ketoacidosis and the Hyperosmolar Hyperglycaemic State in Adults, 602Philip Newland-Jones, Mayank Patel, and Ketan Dhatariya Part 7 Microvascular Complications in Diabetes 42 Pathogenesis of Microvascular Complications, 615Allan Flyvbjerg 43 Diabetic Retinopathy, 629Toke Bek 44 Diabetic Nephropathy, 640Peter Rossing and Allan Flyvbjerg 45 Diabetic Neuropathy, 655Shazli Azmi, Uazman Alam, and Rayaz A. Malik Part 8 Macrovascular Complications in Diabetes 46 Pathogenesis of Macrovascular Complications in Diabetes, 681Jakob A. Ostergaard, Tomasz J. Block, Sophia Dahm, Waheed Khan, and Karin A.M. Jandeleit-Dahm 47 Hypertension and Diabetes, 700Peter M. Nilsson 48 Dyslipidaemia and Diabetes, 713Adie Viljoen, Ahmed Handhle, and Anthony S. Wierzbicki 49 Ischaemic Heart Disease in Diabetes, 724Michael Lehrke and Nikolaus Marx 50 Heart Failure and Diabetes, 732Ambarish Pandey, Kershaw V. Patel, and Subodh Verma 51 Cerebrovascular Disease and Diabetes, 745Colum F. Amory, Jesse Weinberger, and Travis S. Smith 52 Peripheral Vascular Disease, 755Henrik H. Sillesen Part 9 Other Complications of Diabetes 53 Foot Problems in People with Diabetes, 771Frank L. Bowling, Keeley J. Foley, and Andrew J.M. Boulton 54 Sexual Function in Men and Women with Diabetes, 780Kirsty Winkley, Camilla Kristensen, Jackie Fosbury, and David Price 55 Gastrointestinal Manifestations of Diabetes, 796Michael Camilleri and Adil E. Bharucha 56 Diabetes and Oral Health, 810Palle Holmstrup, Christian Damgaard, and Allan Flyvbjerg 57 Diabetes and Non-alcoholic Fatty Liver Disease, 820Alessandro Mantovani, Giovanni Targher, and Christopher D. Byrne 58 The Skin in Diabetes, 838Paul Devakar Yesudian 59 Bone and Rheumatic Disorders in Diabetes, 853Andrew Grey and Nicola Dalbeth 60 Diabetes and Cancer: Risk, Outcomes, and Clinical Implications, 867Ellena Badrick, Emily J. Gallagher, and Andrew G. Renehan 61 Diabetes and Infections, 878Andrea O.Y. Luk and Clive S. Cockram 62 Sleep and Diabetes, 897Sonya Deschênes, Amy McInerney, and Norbert Schmitz Part 10 Psychosocial Aspects of Diabetes 63 Psychosocial and Behavioural Aspects of Diabetes, 907Frans Pouwer and Jane Speight 64 Role of Cognitive Function in Managing People with Diabetes, 922Tamsin Santos, Chelsea Baird, Sally Eastwood, Kerrie Shiell, and Joseph E. Ibrahim 65 Mental Disorders and Diabetes, 933Najma Siddiqi, Marietta Stadler, and Richard I.G. Holt 66 Social Aspects of Diabetes, 956Brian M. Frier and Mark W.J. Strachan 67 Social Determinants of Diabetes, 973Keri F. Kirk, Gerald McKinley, Briana Mezuk, and Erica Spears Part 11 Diabetes in Special Groups 68 Ethnic, Cultural, and Religious Aspects to the Management of Diabetes, 987Wasim Hanif, Sarah N. Ali, and Vinod Patel 69 Diabetes in Childhood, 999Jennifer M. Ikle, Ananta Addala, and David M. Maahs 70 Adolescence and Emerging Adulthood: Diabetesin Transition, 1019Charlotte W. Chen and Lori M.B. Laffel 71 Diabetes in Pregnancy, 1034David R. McCance and Laura Cassidy 72 Diabetes in Old Age, 1072Ahmed H. Abdelhafiz and Alan J. Sinclair 73 Diabetes at the End of Life, 1085Trisha Dunning and June James Part 12 Delivery and Organization of Diabetes Care 74 The Role of the Multidisciplinary Team across Primary and Secondary Care, 1097Samuel Seidu and Kamlesh Khunti 75 Models of Diabetes Care in Low-and Middle-Income Countries, 1107David Beran, Sigiriya Aebischer Perone, and Maria Lazo-Porras Part 13 Future Directions 76 Immunotherapies for Type 1 Diabetes, 1125Jesper Johannesen and Flemming Pociot 77 Stem Cell Therapy in Diabetes, 1137Angelo Avogaro and Gian Paolo Fadini 78 Gene Therapy for Diabetes, 1144Veronica Jimenez and Fatima Bosch 79 Future Drug Treatments for Type 2 Diabetes, 1154Clifford J. Bailey Index, 1167
£193.46
McGraw-Hill Education Greenspans Basic and Clinical Endocrinology Tenth
Book SynopsisA full-color guide to the entire field of clinical endocrinology and its scientific underpinnings â updated with the latest breakthroughs and developmentsA Doodyâs Core Title for 2022! Greenspanâs Basic & Clinical Endocrinology delivers a succinct, leading-edge overview of the underlying molecular biology of the endocrine system and the latest perspectives on the diagnosis and treatment of specific diseases and disorders. Featuring an enhanced design that includes hundreds of full-color illustrations and clinical photographs, Greenspanâs is a true must-have during traditional or integrated courses in endocrinology, endocrinology rotation, or exam prep in internal medicine and endocrinology and as reference for disease management.Greenspanâs provides clinically relevant coverage of metabolic bone disease, pancreatic hormones and diabetes mellitus, hypoglycemia, obesity, geriatric endoc
£68.39
Hay House Inc Fat for Fuel
Book SynopsisTrade Review"Dr. Joseph Mercola has been a shining beacon of health wisdom and freedom for decades. His latest book, Fat for Fuel, is a masterpiece of cutting-edge research and practical application. This information, if applied, holds the key to sustainable weight loss and enhanced energy. More than that, this lifestyle plan can help reverse chronic illness such as heart disease, diabetes, and even cancer."— Christiane Northrup, M.D., New York Times best-selling author of Women’s Bodies, Women’s Wisdom and Goddesses Never Age"I truly believe that the concept of Mitochondrial Metabolic Therapy will have significant impact on health. As I mentioned in my book, cancer is not likely to occur in people with healthy mitochondria. Dr. Mercola has expanded this concept to a broad range of chronic diseases that involve mitochondrial dysfunction. He provides a clear rationale as well as guidelines for implementation of MMT. This book should be read by anyone interested in maintaining their health without toxic pharmaceuticals."— Thomas Seyfried, Ph.D., author of Cancer as a Metabolic Disease and professor of biology at Boston College"Dr. Mercola’s Fat for Fuel eloquently presents the leading edge of science, exploring how best to power your body. This is a life-changing text that not only provides a deep dive into why choosing fat as our primary fuel source powerfully correlates with health and disease resistance, but also delivers in terms of how the reader can easily bring about this fundamentally important change. Health, on a global scale, has suffered profoundly as a consequence of commercially influenced dietary recommendations. Mercola’s science-based refutation of this status quo provides a welcome and compassionate response, allowing readers to regain and maintain optimal health."— David Perlmutter, M.D., F.A.C.N., board-certified neurologist and author of the #1 New York Times bestseller Grain Brain and The Grain Brain Whole Life Plan"This remarkable book presents a truly revolutionary program that can help millions of people achieve optimal health. Dr. Mercola clearly explains the importance of mitochondria for metabolic function and carefully guides his readers with detailed practical advice for enhancing their activity. Fat for Fuel will change the way you think about nutrition and your health."— Leo Galland, M.D., author of The Allergy Solution"In Fat for Fuel, Dr. Mercola beautifully lays out the history—and the myths—behind the high-carbohydrate, low-fat diet that has been at the root of so much illness and death in the last half-century. Dr. Mercola is one of the few who have properly understood and embraced my long-standing belief that one’s health and lifespan is mostly determined by the proportion of fat versus sugar one burns over a lifetime. He also understands that excess protein creates another whole set of health-eroding issues. Anyone who values their health should read this book."— Ron Rosedale, M.D. "The world of nutrition is more confusing than ever. But one thing has become increasingly evident over the past decade: teaching our bodies to use fat instead of glucose as the main fuel source has immense potential to support patients suffering from some of the most devastating chronic diseases. Dr. Mercola’s Fat for Fuel will be an invaluable resource for me in two ways: personally, because I’m a cancer patient myself striving to create an environment that will keep my disease at bay, but also professionally as a nutritional therapist. Fat for Fuel will help me inform, educate, and guide my clients."— Patricia Daly, dipNT, mNTOI, mBANT"Fat for Fuel is another fact-based, insightful book by the visionary Joseph Mercola that will not just change your life, but could literally save it. Dr. Mercola understands how food can preserve wellness or destroy it. Boldly challenging old myths about fat, diet, and healing, he gives practical, step-by-step instructions that will empower you to take control of your health whether you are sick and want to get well, or are healthy and want to stay well."— Barbara Loe Fisher, co-founder, National Vaccine Information Center"Fat for Fuel is required reading for anyone wishing to radically and expeditiously address a current health crisis and also for those of us seeking to ameliorate genetic predispositions as we age."— Karen Becker, D.V.M."Dr. Mercola’s lifetime of research reaches a crescendo with Fat for Fuel. Every page is a distillation of his genuine passion to optimize human health through diet."— Travis Christofferson, author of Tripping over the Truth: How the Metabolic Theory of Cancer Is Overturning One of Medicine’s Most Entrenched Paradigms"Fat for Fuel is a powerhouse of practical, evidence-based information for the clinician and consumer alike. With so much conflicting information in the nutrition world, this book serves as a critical resource for every physician in training or in practice, and for every person eager to avoid the need for those doctors."— Zach Bush, M.D., endocrinologist"Fat for Fuel is a powerful manifesto reexamining the fat-phobic paradigm that has long dominated the thinking about health and nutrition. This is an extremely valuable guidebook for those seeking to understand and implement transformational dietary changes to boost their metabolic and cellular function. By shifting away from the idea of glucose as the optimal source of energy, Dr. Mercola shows how we can harness the benefits of fat and ketones for clean-burning fuel in the quest for optimal health."— Michael Stroka, J.D., M.B.A., M.S., C.N.S., L.D.N., executive director, Board for Certification of Nutrition Specialists"In 2017, we have many chronic illness epidemics in the USA. At the center of most of those epidemics is the toxic, nutrient-depleted, dysfunctional human cell. And research is now showing us that the most important organelle in that cell contributing to most of these diseases is the mitochondria. In his book Fat for Fuel, Joe Mercola has given us a practical blueprint for how to revive our mitochondria using diet as a powerful foundation, with a few other added simple tools, such as intermittent fasting, exercise, light therapy, and some supplemental nutrients. Dr. Mercola tested the Mitochondrial Metabolic Therapy recommendations he makes in this book on himself, with many months of trials and errors and continuous glucose monitoring. He also amassed impressive scientific research from the literature to prove what he recommends on these pages. I highly endorse Fat for Fuel as the most practical do-it-yourself guide available today for people to take back control of their health and resolve chronic illnesses."— W. Lee Cowden, M.D., M.D.(H), chairman of scientific advisory board, Academy of Comprehensive Integrative Medicine"Science has already shown that eating fat can make you thin. In this pathbreaking book, Dr. Joseph Mercola goes a critical step further, revealing that using fat as your main fuel source can heal your body at a mitochondrial level, restoring energy and well-being and even helping fight cancer and other diseases. Impeccably researched and passionately argued, Fat for Fuel dispels dangerous myths about ‘healthful’ diets, reveals truths the food industry won’t tell you about the food you eat, and starts you on a path to radically transforming your health."— Mark Hyman, M.D., #1 New York Times best-selling author of Eat Fat Get Thin and Director of the Cleveland Clinic’s Center for Functional Medicine"Fat for Fuel is a landmark contribution from Dr. Joe Mercola. . . . Metabolism at its core consists of how our mitochondria utilize nutrients, and Dr. Mercola educates his readers on how to choose the nutrients that optimize mitochondrial function. This book will contribute greatly toward our health goals for our entire population as more and more health-care professionals wake up to this understanding of the importance of optimizing mitochondrial metabolism. Fat for Fuel brings mitochondrial function into the mainstream for the healthy benefit of everyone. Bravo!"— J. William (Will) LaValley, M.D."Dr. Mercola is a deep thinker with a passion for seeking knowledge about the inner workings of the human body and an open mind about the role of successful alternative treatments that have hard evidence behind them. Dr. Mercola has a knack for describing difficult scientific concepts in simple and entertaining terms that a non-expert can understand. The information he provides is priceless: the result of decades of searching for, and finding, the truths that will keep you on the path to healthy living. You can’t afford not to read this book!"— Stephanie Seneff, Ph.D., senior research scientist, MIT"Dr. Mercola proves once again that he is at the very forefront of natural healing and wellness. With medical science understanding more and more how mitochondrial dysfunction leads to chronic disease, Dr. Mercola provides a simple, natural healing plan with this important new book."— Jason Fung, M.D., nephrologist and author of The Complete Guide to Fasting"A revolution is growing in medicine, one that revolves around a change from seeing the cell as a membrane-bound bag of water controlled by the all-powerful DNA to a more fluid conception of the cell centered on the central role of the mitochondria. Dr. Mercola is at the forefront of this exciting revolution, and this book gives you both the theoretical basis and practical suggestions for supporting your mitochondria and regaining better health. I would encourage everyone to read this book and strongly consider following Dr. Mercola’s many helpful suggestions and guidelines."— Thomas Cowan, M.D."A book like Fat for Fuel has been a long time coming. Backed by a wealth of research, Dr. Mercola makes the definitive case that fat, not sugar, is the power source on which our bodies are meant to run, and he outlines what changes we can make in our daily lives to use fat as fuel. KU Integrative Medicine has been waiting for this book!"— Jeanne A. Drisko, M.D., C.N.S, F.A.C.N., Director, KU Integrative Medicine, and Riordan endowed professor of orthomolecular medicine, University of Kansas Medical Center"Dr. Mercola is one of the most brilliant minds in modern medicine, and he has achieved a true masterpiece with Fat for Fuel. Why? The book defies the status quo and reveals the truth behind everything from why fasting is a healthy habit to why you need to become a fat-burning machine. He even shocks us with the details on how iron can negatively impact mitochondrial health (you’ll be surprised). This book is a must-read if you want to optimize your body and brain while systematically eliminating a host of risk factors for chronic disease."— Ben Greenfield, BenGreenfieldFitness.com (Dr. Mercola’s favorite fitness podcast)"In a bold voice and in plain language, Dr. Mercola continues his role as nutrition pioneer for America and the world. This book will educate, embolden, and empower consumers to take charge of their health destiny. Dr. Mercola, pro-health instead of pro-industry, shows us how we can bring in healthy fats and take a number of other key steps to right our own ships. This book should be a wake-up call to spur the medical and dental professions to take nutrition counseling seriously."— Charlie Brown, J.D., Consumers for Dental Choice"Fat for Fuel consolidates the latest cutting-edge metabolic discoveries into an easy-to-follow system for optimizing your health at the cellular level. It gives people the tools and the knowledge to empower themselves and customize their own dietary therapy."— Aaron Davidson, founder of Cronometer "Fat for Fuel goes well beyond a book on the health benefits of eating the right types of fat to offer tremendous insights on how to power up your health by ramping up metabolism and boosting cellular energy. It is an incredible book written by a truly insightful thought leader. My hope is that this book will produce the tipping point leading to needed changes in our collective thinking about the power of nutrition as medicine. I highly recommend this book!"— Michael T. Murray, N.D., co-author of The Encyclopedia of Natural Medicine"Dr. Mercola presents a well-thought-out, well-written case for a healthy diet that is surprisingly high in fats. Over the years I taught many a student about mitochondrial function, and it is a pleasure to see proper emphasis on this all-important cellular powerhouse. Fat for Fuel deserves serious consideration by anyone looking for practical, powerful ways to improve their health."— Andrew W. Saul, Ph.D., editor, Orthomolecular Medicine News Service"Fat for Fuel is a crucial read to obtain and maintain health, especially in the modern pandemic of inflammation-driven chronic diseases. This important book teaches principles most people have not yet heard and extends its reach beyond the small group of practitioners around the world who are already utilizing these methods. Implementing the principles outlined in this book has proved life-changing for thousands and I now expect that this information will transform millions. These tools and strategies are ‘the real deal,’ and a proven answer to our current state of dis-ease. The science presented here is clear and well-documented and will change the way you think about what really brings you health and healing."— Daniel Pompa, D.C."Fat for Fuel comes at the perfect time. With the cost of health care soaring, we have to take responsibility for protecting our health instead of simply treating disease. Understanding the mechanisms of how we function is essential to a healthy body and brain, and modern-day revolutionary Dr. Mercola has relentlessly dug through the research to bring this latest and greatest knowledge of our bodies to the bookshelf. Not only does this page-turner highlight the need for fat in our diet, it shows us how to prepare our bodies to process and utilize it most efficiently—a key ingredient in the overall strategy to attain optimal health."— Erin Elizabeth, investigative journalist, author of In the Lymelight, and founder of HealthNutNews.com"I had been playing around with low-carb and keto cooking on and off for a year but not making much progress toward my weight-loss goals. After reading Fat for Fuel I understand that I was limited by a kindergarten-level understanding of the ketogenic diet compared to what I needed to know and do in order to be successful. My father’s recent death due to Alzheimer’s has motivated me to be deadly serious about doing whatever I can to avoid this and other chronic diseases. I’ve read hundreds of nutrition books over my lifetime but this one is my favorite and the one I know will make the biggest impact on your health if you have the commitment to follow it to the letter. Once again, an outstanding contribution from Dr. Mercola!"— Dr. Kendra Pearsall, N.M.D., founder of Enlita.com"Clear the brain fog, build up your energy, prevent disease, be happy! Dr. Mercola shatters the fat myth and shows us the way to ultimate health and healing."— Dr. Alberto Villoldo, co-author of Power Up Your Brain
£16.99
John Wiley and Sons Ltd Nutritional and Metabolic Bases of Cardiovascular
Book SynopsisExtraordinary advances in the understanding of the relationships between nutrition, metabolism, and cardiovascular disease have prompted a systematic reappraisal of recent knowledge in the field.Table of ContentsContributor list. Foreword. Preface. Section I Nutrition and Obesity. 1 Basics of Energy Balance (Luca Scalfi, Fabrizio Pasanisi, & Franco Contaldo). 2 Genotype-Phenotype Associations: Modulation by Diet and Obesity (José M. Ordovas&Mireia Junyent). 3 Etiopathogenesis of Obesity (Marie-Eve Mathieu & Angelo Tremblay). 4 The Epidemiology of Obesity (W. Philip T. James & Rachel Leach). 5 Pre-Diabetes in Obese Adolescents: Pathophysiologic Mechanisms (Anna M.G. Cali & Sonia Caprio). 6 Complications and Comorbidities of Obesity (Franco Contaldo, Fabrizio Pasanisi, & Mario Mancini). 7 Cardiovascular Damage in Obesity and Metabolic Syndrome, (Giovanni de Simone, Richard B. Devereux, & Oreste de Divitiis). 8 Treatment of Obesity: Beneficial Effects on Comorbidities and Lifespan (George A. Bray). 9 A Review of Results from Swedish Obese Subjects, SOS (Lars Sjöström). 10 Optimal Nutrition for Health and Longevity (Francesco P. Mancini & Mario Mancini). Section II Metabolic Syndrome and Diabetes. 11 Definition and Diagnostic Criteria for Metabolic Syndrome (Wm. James Howard, Giovanni de Simone, & Barbara V. Howard). 12 Cardiac and Vascular Effects of Adipocytokines in Normal and Obese Individuals: The Concept of Cardiometabolic Risk (Roberto Vettor, Claudio Pagano, Marco Rossato, & Giovanni Federspil). 13 Dietary Carbohydrates, Overweight and Metabolic Syndrome: The Role of Glycemic Index in a Healthy Diet (Angela Albarosa Rivellese & Rosalba Giacco). 14 Metabolic Effects ofWholegrain Foods in Relation to Composition, Structure and Type of Food (Hannu Mykk¨anen, Marjukka Kolehmainen, Isabel Bondia Pons, & Kaisa Poutanen). 15 Complex Dietary Patterns (Mediterranean Diet, Vegetarian/Vegan Dietary Models): Impact on Carbohydrate and Lipid Metabolism (Jim Mann). 16 Physical Activity and Risk of Cardiovascular Diseases (Eduardo Farinaro, Elisabetta Della Valle, & Roberto Grimaldi). 17 Physical Exercise in the Prevention and Treatment of Obesity, Diabetes, and Metabolic Syndrome (Virginie Messier, Anne-Sophie Brazeau, Rémi Rabasa-Lhoret, & Antony Karelis). 18 Functional Foods for Diabetes and Obesity (Gabriele Riccardi, Brunella Capaldo, & Olga Vaccaro). Section III Hypercholesterolemia and Early Atherosclerosis. 19 Familial Dyslipidemias: From Genetics to Clinical Picture (Paolo Rubba,Marco Gentile, Salvatore Panico, & Paolo Pauciullo). 20 HDL, Reverse Cholesterol Transport, and Atherosclerosis (Guido Franceschini, Monica Gomaraschi, & Laura Calabresi). 21 Role of Polyunsaturated Omega-3 Fatty Acids and Micronutrient Intake on Atherosclerosis and Cardiovascular Disease (Francesco Visioli, Doriane Richard, Pedro Bausero, & Claudio Galli). 22 Alcohol Intake, Dyslipidemia, and CVD (Saverio Stranges & Maurizio Trevisan). 23 Dyslipidemia in Chronic Renal Disease (Carmine Zoccali). 24 Subclinical Hypothyroidism, Dyslipidemia, and Cardiovascular Risk (Jan Kvetny & Jørgen Gram). 25 Genetic Influences on Blood Lipids and Cardiovascular Disease Risk (Jose M. Ordovas & Mireia Junyent). 26 The Relationship between Dyslipidemia and Inflammation (Branislav Vohnout, Giovanni de Gaetano, Maria Benedetta Donati, & Licia Iacoviello). 27 Dyslipidemia in Children: Diagnosis and Management (Leiv Ose). 28 Early Atherosclerotic Lesions in Childhood and Adolescence (Paolo Rubba, Gabriella Iannuzzo, Fabrizio Jossa, Gennaro Marotta, & Arcangelo Iannuzzi). 29 Phytosterols, Plasma Lipids and CVD Risk (Gerd Assmann & Udo Seedorf). 30 Nitric Oxide in the Development of Vascular Diseases and Regenerative Angiogenesis (Claudio Napoli & Louis J. Ignarro). 31 Impact of Treating Dyslipidemia on Cardiovascular Events (? Zeljko Reiner & Diana Mua?cevi´c-Katanec). 32 Evolution of the Lipid Clinic, 1968–2008 (Barry Lewis). Section IV Nutrition, Hypertension, and Cardiovascular Disease. 33 From Abdominal Adiposity to Hypertension: Mechanisms and Clinical Implications (Albert P. Rocchini). 34 Role of the Adipose-Tissue Renin-Angiotensin-Aldosterone System in Obesity and Obesity-Associated Hypertension (Stefan Engeli). 35 Relationship of Dietary Electrolyte Intake to Blood Pressure Regulation and Hypertension (Francesco P. Cappuccio). 36 Genetic Susceptibility and Metabolic Bases of BP Salt Sensitivity (Ferruccio Galletti & Pasquale Strazzullo). 37 Are Sodium and Potassium Intake Independent Predictors of Cardiovascular and Cerebrovascular Events?(Pasquale Strazzullo, Gianvincenzo Barba, & Renato Ippolito). 38 Metabolic and Dietary Influences on Sympathetic Nervous System Activity (Elaine Ku, Tanzina Nasreen, Jeanie Park, & Vito M. Campese). 39 Improved Nutrition: Key to Solving the Populationwide Blood Pressure Problem (Jeremiah Stamler). 40 Alcohol and Coffee Intake, BP, and Cerebrovascular Disorders (Tanika N. Kelly & Jiang He). 41 Fruit and Vegetable Consumption, Hypertension, and Risk of Stroke (Lydia A. Bazzano & Domnica Fotino). 42 Complex Dietary Patterns and Blood Pressure (Alfonso Siani & L. Aldo Ferrara). 43 Role of Obesity and Metabolic Alterations in Hypertensive Renal Disease and in Chronic Kidney Disease (Carmine Zoccali, Daniela Leonardis, & Francesca Mallamaci). 44 Current Experience and Future Perspectives forWorldwide Reduction of Dietary Salt Intake (Naomi M. Marrero, Feng J. He,& Graham A. MacGregor). Section V Hemostasis and Thrombosis: From Nutritional Influences to Cardiovascular Events. 45 Risk Factors for Arterial Thrombosis (Giovanni de Gaetano, Romina di Giuseppe, & Maria Benedetta Donati). 46 Platelets, Leukocytes, and VascularWall Interactions in Cardiovascular Disease: Modulatory Effects of Dietary Polyphenols (Chiara Cerletti, Serenella Rotondo, & Giovanni de Gaetano). 47 Gene–Environment Interaction in the Molecular Regulation of Plasma Coagulation Proteins (Maurizio Margaglione, Elvira Grandone, Matteo N.D. Di Minno, & Giovanni Di Minno). 48 Nutrition and Cardiovascular Disease: ?-3 PUFA (Elena Tremoli, Matteo Nicola Dario Di Minno & Giovanni Di Minno). 49 Nutrition and Cardiovascular Disease: Homocysteine (Matteo Nicola Dario Di Minno, Elena Tremoli, & Giovanni Di Minno). Section VI Nutrition, Metabolism, and the Aging Process. 50 Nutrients and Cellular Aging (Roberto Paternò & Francesco P. Mancini). 51 Interaction between Diet and Genes on Longevity (Annibale Alessandro Puca, Chiara Viviani Anselmi, & Thomas Perls). 52 The Role of Diet on Cognitive Decline and Dementia (Alfredo Postiglione & Giovanni Gallotta). 53 Neurovascular Protection in Old Age (Jean-Marc Bugnicourt & Jean-Marc Chillon). 54 Cardiovascular Risk Factors and Their Treatment in the Oldest Old (Kay-Tee Khaw). 55 Nutrition and Lifespan in Developing Countries (Arun Chockalingam). Index.
£136.95
John Wiley and Sons Ltd Metabolic Syndrome and Cardiovascular Disease
Book SynopsisTrends indicate that the metabolic syndrome will become the leading risk factor for heart disease. Now more than ever you need an all-in-one reference that provides the tools and practical advice you need to: Identify at-risk patients Explain individual contributing factors Aid in patient education and motivation Direct comprehensive care and Choose the most appropriate interventions Comprehensively revised to reflect leading-edge research and now organized to facilitate easy access to essential information and clinically-relevant guidance, Metabolic Syndrome and Cardiovascular Disease, 2e offers this and more. Not only will you receive a solid understanding of the pathophysiology underlying the metabolic syndrome and cardiovascular disease but also the rationale for today's most effective treatments. What's new? Filled with timely new content, Table of ContentsPreface viii List of Abbreviations ix 1 The Metabolic Syndrome: A Relevant Concept? 1 2 Mitochondria 3 Background 3 Cellular respiration 6 Modulation of mitochondrial metabolic activity 9 Factors that affect mitochondrial number and activity 10 Peroxisome proliferator–activated receptor gamma coactivator-1 11 Mitochondrial production of prooxidant species 12 Mitochondria and nitric oxide 15 Mitochondrial calcium homeostasis 17 The mitochondrial permeability transition 18 Apoptosis 22 Causes for mitochondrial dysfunction 22 Implications of mitochondrial dysfunction 27 Mitochondrial dysfunction and cardiovascular disease 27 Mitochondrial dysfunction and metabolic disease 29 Conclusion 32 Bibliography 34 3 Telomeres 40 Telomere structure 40 Telomere function 41 Telomere shortening 41 Telomere dysfunction 42 Physiologic age 42 Gender differences 43 Telomerase 43 Cell senescence and apoptosis 46 Telomeres in aging 49 Risk factors for cardiometabolic disease 51 Telomeres senescence and chronic disease 54 Cardiovascular disease 54 Insulin resistance and type 2 DM 57 Conclusion 58 Bibliography 60 4 The FoxO Transcription Factors and Sirtuins 64 Forkhead transcription factors 64 Functions of FoxO 68 Cardiovascular forkhead effects 70 Metabolic forkhead effects 72 Histone acetylation and deacetylation 75 Sirtuin deacetylases 76 Sirtuin regulation 78 Antiinflammatory cardiovascular and myocyte sirtuin effects 80 Sirtuin effects on metabolism 81 Sirtuins and cell longevity 83 Forkhead deregulation and insulin resistance 85 Paradoxical effect of nutrition versus stress on cell death suppression 87 Conclusion 89 Bibliography 90 5 Insulin and Insulin-Like Growth Factor 96 Anabolism and catabolism 96 Control of plasma glucose 96 Insulin 97 Insulin receptor location 98 Metabolic insulin signaling 101 Insulin-mediated glucose uptake 103 Nutrient storage and metabolism 104 Vascular and antiinflammatory effects 106 Mitogenic action 107 Insulin-like growth factor 108 Insulin and IGF impact on cell longevity 111 Amylin 113 Glucagon 113 Conclusion 113 Bibliography 114 6 Oxidative Stress 120 Free radicals 120 Oxidases 120 Sources for free radicals 123 Endogenous antioxidants 124 Physiologic functions of oxidative stress 126 Mechanisms of oxidative damage 127 Cellular stress-sensitive pathways 127 Cellular targets of oxidative stress 128 Oxidative stress-related diseases 129 Endothelial dysfunction with oxidative stress 129 Cardiovascular disease 130 Insulin resistance and type 2 DM 131 Conclusion 133 Bibliography 134 7 Mental Stress 139 Stress responses 139 Central stress pathways 139 Peripheral stress pathways 140 Fight-flight-fright responses to acute stress 142 Sequelae of sustained passive stress 142 Inflammatory effects of stress pathways 143 Vascular and lipoprotein effects of stress pathways 143 Stress impact on body weight 146 Metabolic effects of stress pathways 146 Depression and other mood disturbances 149 Conclusion 152 Bibliography 153 8 Sleep 159 Stages of sleep 159 Cardiovascular parameters during normal sleep 160 Function of sleep 161 Sleep duration 164 Circadian rhythm 165 Examples of circadian regulation 166 Neurohormonal modulation of wakefulness 168 Neurohormonal modulation of sleep 170 Sleep–arousal transitions 172 Sleep deficit 174 Pathophysiologic effects of sleep debt 175 Sleep debt and risk of cardiometabolic disorder 177 Sleep disorders 179 Conclusion 182 Bibliography 183 9 Inflammation 192 Immune responses 192 Selected participants in the inflammatory response 193 C-reactive protein 198 The renin–angiotensin–aldosterone system and inflammation 199 Inflammation and chronic diseases 202 Inflammation endothelial and vascular dysfunction 202 Inflammation and atherosclerosis 205 Acute inflammation carbohydrate metabolism and dyslipidemia 210 Chronic inflammation and the metabolic syndrome 213 Causes for systemic inflammation 215 Conclusion 218 Bibliography 219 10 Adipose Tissue and Overweight 228 Energy storage 228 Diverse fat depots 230 Adipose tissue as immune organ 234 Adipose tissue as endocrine organ 236 Adipokines with beneficial cardiometabolic effect 237 Adipokines with detrimental cardiometabolic effect 244 Obesity comorbidities and cardiovascular disease 250 Obesity insulin resistance and diabetes 252 Conclusion 254 Bibliography 255 11 Weight Loss and Diet 266 Homeostatic responses to weight gain and weight loss 266 Adipose weight loss effects 267 Antiinflammatory vasculoprotective and metabolic effects of weight loss 267 Dietary intervention for weight loss 269 Calorie restriction 270 Surgical intervention 277 Diet 279 Exercise as adjunct to weight loss 289 Conclusion 289 Bibliography 291 12 Skeletal Muscle and Exercise 303 Myocyte structure and function 303 Metabolic adaptations in skeletal muscle 305 Energy sensors 311 Skeletal muscle in inflammation 317 Skeletal muscle in insulin resistance 318 Exercise effect on inflammation and oxidative stress 320 Exercise effect on metabolism in obesity 322 Exercise effect and cardiovascular health 322 Exercise and insulin resistance 325 Exercise and mortality 328 Exercise recommendation 331 Conclusion 332 Bibliography 334 13 Lipids Atherogenic Dyslipidemia and Therapy 347 Apolipoproteins 347 Lipoproteins 347 Apo A-containing lipoproteins 348 Apo B-containing lipoproteins 355 Apolipoproteins C D and E 360 The triglyceride lipase family 360 The normal metabolism of free fatty acids 363 Inflammation and hepatic insulin resistance 365 Atherogenic dyslipidemia in insulin resistance 369 Lipid-lowering therapy 372 The HMG CoA reductase inhibitors 374 Nicotinic acid 387 The fibric acid derivatives 388 Bile acid sequestrants 391 Ezetimibe 391 CETP inhibition 391 Conclusion 392 Bibliography 393 14 The Endothelium Cardiovascular Disease and Therapy 409 Endothelial function 409 Nitric oxide synthase and eNOS 409 Endothelial NO synthesis 410 Specific enhancers of NO synthesis 413 Functions of nitric oxide 415 Shear stress and vascular function 418 Mechanisms of endothelial dysfunction 420 Insulin insulin resistance and endothelial dysfunction 424 Implications of endothelial dysfunction 428 Assessment of endothelial function 430 Hypertension 432 Cardiomyopathy 434 Coronary and peripheral vascular disease 440 Pharmacologic antagonism of the renin–angiotensin–aldosterone system and endothelin-1 443 Beta-adrenergic blockade 448 Phosphodiesterase-5 inhibitors 449 Conclusion 450 Bibliography 451 15 Insulin Resistance Metabolic Syndrome and Therapy 468 Diagnostic criteria for the metabolic syndrome 468 Prevalence of the metabolic syndrome 470 Insulin resistance 470 Causes of insulin resistance 474 Pathways toward insulin resistance 476 Pharmacologic therapy to improve insulin sensitivity 480 Conclusion 483 Bibliography 484 Index 491
£110.15
Barcharts, Inc Endocrine System
Book SynopsisNot sure of where the superior colliculus is in the human brain? Want to find out what components make up the pancreas? Look no further than our comprehensive 3-panel guide! Each area of the endocrine system is clearly detailed and labeled through full-color illustrations by award-winning artist Vincent Perez.
£6.00
Lippincott Williams and Wilkins Understanding Diabetes Anatomical Chart
Book SynopsisThe 3rd edition of Understanding Diabetes has been updated with new and additional information.Includes a general definition of diabetes.Describes how diabetes is diagnosed. Illustrates what happens in diabetes and insulin action in a body cell. Also describes the following types of diabetes:type I diabetestype 2 diabetes including factors causing insulin resistancepre-diabetesprenatal diabetesDiscusses diabetes in youth.Lists symptoms and risk factors. And includes tips for successful diabetes management.Available in the following size and formats:20' x 26' heavy paper ISBN 978-14698-9489-820' x 26' laminated with eyelets at top corners ISBN 978-14698-9492-8printed in USA
£14.03
LWW Understanding Type 2 Diabetes Anatomical Chart
Book SynopsisThe third edition of our chart, Understanding Type 2 Diabetes uses patient friendly illustrations and text to explain type 2 diabetes and the complexity of type 2 diabetes. Defines type 2 diabetes and the role of glucose and insulin in the body Lists risk factors, symptoms and complications. Illustrates the many different factors that contribute to high blood sugar and insulin resistance. Also talks about management and gives management tips.Shows glucose molecules from the digestive system and insulin molecules from the pancreas traveling in a blood vessel. Illustrations visually compare a normal body cell to a body cell with diabetes and show when the cell develops a resistance to insulin, making it more difficult for glucose to enter the cell and leading to build-up of glucose in the blood vessel.The chart textually and visually presents complications from the disease: heart disease, stroke, vascular disease, nerve damage (neuropathy), kidney disease (nephrop
£14.03
Lippincott Williams and Wilkins Manual of Endocrinology and Metabolism
Book Synopsis Selected as a Doody's Core Title for 2022!Ideal for all health care professionals who evaluate, diagnose, treat, or refer patients with endocrine disease or disorders, Manual of Endocrinology and Metabolism, Fifth Edition , brings together nearly 150 global authorities who share their knowledge and expertise on endocrine disorders in children, adolescents, and adults. Using a concise outline format, this thoroughly updated manual presents clinical information and protocols needed in everyday practice, with an emphasis on diagnosis and treatment. Succinct chapters and an abundance of tables and diagrams make complex information easy to find and understand. Includes coverage of fundamental understandings and treatment modalities as well as recent therapies, new methods of treatment, new understandings of endocrine physiology, and new surgical approaches to disease states Covers evaluation, pathophysiology, management, and treatment at ev
£61.19
Nova Science Publishers Inc Neurochemistry of Metabolic Diseases: Lysosomal
Book SynopsisMetabolic disorder caused by altered levels of metabolism resulting pathophysiological abnormalities often leads to childhood death. Several new developments on metabolic diseases research have been emerging. Gaucher disease is a lysosomal storage disorder caused by glucocerebrosidase gene mutations resulting glucocerebrosidase deficiency. Current studies show that the same gene mutations also contribute to the Parkinson''s disease. Tetrahydrobiopterin (BH4) has been widely used in treating patients with Phenylketonuria over a decade. Recent studies reveal that patients treated with BH4 over one-year period showed reduced levels of serum B12, folate and iron intake and therefore patients under chronic BH4 treatment needed to be advised to have additional micronutrients along with BH4. Macrocephaly was used as one of the important features to diagnose Canavan disease. However, a recent study showing a child with aspartoacylase gene mutation developed microcephaly. Hence, Canavan disease phenotype can be either macrocephaly or microcephaly. These are a few examples of recent developments on metabolic diseases research. Therefore, this book was aimed to compose current developments on metabolic diseases research for the use by broad spectrum of experts including Physicians, Neuroscientists, Neurologists, Biomedical researchers, Biochemists, Molecular biologists, Basic Science Researchers and Medical Students.
£163.19
American Diabetes Association Medical Management of Pregnancy Complicated by
Book Synopsis
£34.39
American Diabetes Association Practical Insulin A Handbook for Prescribing
Book Synopsis
£14.52
American Diabetes Association Prediabetes: A Fundamental Text: Pathophysiology,
Book SynopsisPrediabetes affects nearly 90 million U.S. adults and more than 374 million people worldwide. But what exactly is prediabetes, and how should it be treated?Individuals with prediabetes have a high risk of progressing to type 2 diabetes. Diabetes currently affects approximately 30 million adults in the U.S. and 463 million people worldwide, and type 2 diabetes represents 90-95% of the diabetes burden. Individuals with prediabetes also face increased risks of developing several complications including heart disease. Intervention at the prediabetes stage can help prevent progression to type 2 diabetes, and even lead to remission of prediabetes and a return to normal blood glucose regulation (NGR). However, a deeper understanding of the pathobiology of prediabetes is critical to the discovery and delivery of programs for preventing of diabetes.Focusing on prediabetes is compelling: Understanding the numerous risk factors that trigger the initial escape from NGR toward prediabetes provides critical information that enables the precise and timely targeting of preventive interventions to at-risk persons.This book is for clinicians, researchers, public health practitioners and policy makers. It begins with an overview of the demographic, anthropometric, biobehavioral and biochemical factors that drive the transition from normal blood glucose to prediabetes. Emerging knowledge from the fields of genomics, transcriptomics, microRNAs, metabolomics and microbiomics is incorporated into a comprehensive treatise on the pathobiology of prediabetes.Next, the focus shifts to evidence-based management of prediabetes and prevention of type 2 diabetes. Prediabetes seldom remits spontaneously. Lifestyle modification and certain medications can prevent progression from prediabetes to type 2 diabetes and may even induce remission of prediabetes in some people. Landmark diabetes prevention trials are discussed through the prism of their successful translatability in communities around the world. Emphasis is placed on practical adaptations that would enable cost-effective community diabetes prevention initiatives.Interventions utilizing lifestyle modification are prioritized over medications, but novel approaches (including cyclical medication strategy, designer nutraceuticals and metabolic surgery) are also discussed. Current lifestyle intervention protocols have been more effective at preventing progression from prediabetes to type 2 diabetes than they have been at restoring NGR. This book makes the case that reversal of prediabetes and restoration of normal blood glucose levels carries numerous benefits and ought to be the primary goal of intervention in people with prediabetes.
£55.19
Penguin Putnam Inc Fat: The Anthropology of an Obsession
Book Synopsis
£14.36
American Psychiatric Association Publishing Managing Metabolic Abnormalities in the Psychiatrically Ill: A Clinical Guide for Psychiatrists
Book SynopsisPatients with mental and substance use disorders have shown higher rates of morbidity and mortality from medical illnesses than the general population, and physicians are also increasingly aware of adverse effects of psychiatric medications on metabolic and cardiovascular health. In light of these problems, this book addresses an important unmet need of patients with mental disorders—namely, the lack of integration of general medical care with psychiatric care and the related problem of barriers to collaboration and communication among health care providers. Managing Metabolic Abnormalities in the Psychiatrically Ill is the first book to provide a current review of the relationships among psychiatric illnesses, metabolic abnormalities, and treatment, focusing on how clinicians can tailor care to those doubly-afflicted patients. The book integrates research findings into practical clinical guidelines that spell out what psychiatrists need to know when their patients with mental illness suffer from—or are at risk of developing—obesity, diabetes, cardiovascular disease, or the metabolic syndrome. The contributors address those risks that need to be considered in the overall context of treatment, background risks of medical illnesses associated with specific psychiatric disorders themselves, and the means of applying these data to treatment recommendations, monitoring, and clinical practice. Among the specific topics addressed are: • Potential effects of psychotropics on appetite, body weight, and metabolic parameters in obese patients, and the potential effects of anti-obesity agents on psychotic, manic, and depressive syndromes• Increased risk of type 2 diabetes among individuals with psychotic and mood disorders due to neurobiological changes and behavioral effects associated with these disorders• Greater risk for cardiovascular disease among the mentally ill, stressing the importance of mental health providers understanding cardiovascular risk classification and modification strategies• An association between dysregulation of glucose and lipid metabolism and the related risk of type 2 diabetes during treatment with any of the eight second-generation antipsychotics currently available in the United States• Guidance in choice of medications and appropriate monitoring strategies for hyperlipidemia, along with recognition of which antipsychotics pose the greatest risk and an understanding of the common dyslipidemia patterns seen with their use Chapters include key clinical concepts, quick-reference tables, and extensive references, and a final chapter provides an assessment tool for evaluating patients' metabolic risk. Together, the chapters in this book constitute an authoritative clinical guide that enables psychiatrists to better integrate the treatment of patients' mental disorders with their metabolic conditions.Trade ReviewThe final chapter is a superb synthesis of clinical guidelines and can stand alone as the pearl of [Managing Metabolic Abnormalities in the Psychiatrically Ill]. * Doody's Book Review Service *This book is a long overdue text addressing the complicated relationships between psychiatric and metabolic disorders. Its scope is comprehensive yet succinct. Thismulti-authored text was written by leaders on the interface of psychiatric and metabolic disorders along with junior members in the field. This volume offers excellent guidance on assessing, monitoring, and reducing the risks of metabolic abnormalities when prescribing second generation antipsychotic medications that will be invaluable to practicing psychiatrists. -- E. Baron Short, MD * Journal of Psychiatric Practice *Table of ContentsContributorsPrefaceChapter 1. Diabetes: An OverviewChapter 2. The Metabolic SyndromeChapter 3. Severe Mental Illness and ObesityChapter 4. Severe Mental Illness and Diabetes MellitusChapter 5. Cardiovascular DiseaseChapter 6. Antipsychotic-Associated Weight Gain: A Synthesis and Clinical RecommendationsChapter 7. Glucose Metabolism: Effects of Atypical AntipsychoticsChapter 8. Serum Lipids: Effects of AntipsychoticsChapter 9. Metabolic Risk Assessment, Monitoring, and Interventions: Translating What We Have Learned Into PracticeIndex
£42.30
Borm Bruckmeier Publishing Diabetic Nephropathy Pocketcard Set
Book Synopsis
£9.38
Nova Science Publishers Inc Drug-Drug Interactions in the Metabolic Syndrome
Book SynopsisThis book reports updated data from the literature on potential drug-drug interactions occurring between drugs used to treat each individual disease of the metabolic syndrome. The manual is focused on metabolic syndrome drugs. Possible drug-drug interactions and their potential mechanisms are summarised and discussed. Chemical characteristics and mechanisms of action of each drug are also briefly described. Some new anti-obesity, anti-diabetes, lipid lowering and anti-hypertensive drugs were also reported and briefly discussed.
£129.74
Nova Science Publishers Inc Progress in Metabolic Syndrome Research
Book SynopsisSince cardiovascular (heart and blood vessel) disease is the leading cause of death for adults in developed countries, many medical studies focus on treating or preventing heart disease and stroke. The metabolic syndrome, a collection of unhealthy body measurements and abnormal laboratory test results, may identify persons at high risk for developing cardiovascular disease. Aggressive lifestyle modification and possible use of medications to treat the conditions that make up the metabolic syndrome may reduce a person''s chances of developing heart disease or stroke. The metabolic syndrome has also been called syndrome X or insulin resistance syndrome.
£173.24
Nova Science Publishers Inc Enterovirus Infections & Type 1 Diabetes Mellitus
Book SynopsisEnteroviruses have been examined for their possible role in the etiology of type 1 diabetes for nearly 40 years. It is now evident from studies in several countries that enterovirus infection accompanies or precedes the onset of diabetes in many individuals. These evidences include the isolation of coxsackievirus B4 from the pancreas of a child at diagnosis of type 1 diabetes, several epidemiological and prospective studies showing that some cases of type 1 diabetes are strongly associated with enterovirus infections, seasonal incidence studies, case-control studies that show an increased prevalence and levels of IgM antibodies to enterovirus in newly diagnosed patients. Other evidences involves several case studies in which diabetes develops after an enterovirus infections, increased T cell response to enterovirus antigens in type 1 diabetic patients, suggestions that enterovirus infections during pregnancy might initiate the events leading to childhood diabetes, and a higher frequency of enterovirus RNA in the serum/blood of type 1 diabetic patients at diagnosis. This book Provides a better understanding of enteroviral biology and the potential alternative pathogenic mechanisms through which enteroviruses may cause diabetes.
£129.74
Chelsea Green Publishing Co Nutrition in Crisis: Flawed Studies, Misleading
Book SynopsisAlmost every day it seems a new study is published that shows you are at risk for diabetes, cardiovascular disease, or death due to something you’ve just eaten for lunch. Many of us no longer know what to eat or who to believe. In Nutrition in Crisis distinguished biochemist Richard Feinman, PhD, cuts through the noise, explaining the intricacies of nutrition and human metabolism in accessible terms. He lays out the tools you need to navigate the current confusion in medical literature and its increasingly bizarre reflection in the media. At the same time, Nutrition in Crisis offers an unsparing critique of the nutritional establishment, which continues to demonize fat and refute the benefits of low-carbohydrate and ketogenic diets—all despite decades of evidence to the contrary. Feinman tells the story of the first low-carbohydrate revolution fifteen years ago, how it began, what killed it, and why a second revolution is now reaching a fever pitch. He exposes the backhanded tactics of a regressive nutritional establishment that ignores good data and common sense, and highlights the innovative work of those researchers who have broken rank. Entertaining, informative, and irreverent, Feinman paints a broad picture of the nutrition world: the beauty of the underlying biochemistry; the embarrassing failures of the medical establishment; the preeminence of low-carbohydrate diets for weight loss, diabetes, other metabolic diseases, and even cancer; and what’s wrong with the constant reports that the foods we’ve been eating for centuries represent a threat rather than a source of pleasure.Trade Review“In his wonderful book Nutrition in Crisis, Dr. Feinman is speaking as a proper doctor should. He is looking for the why and how of disease. Doctors should provide the interface between the pure science and research and the clinical art of treating patients. Indeed the word ‘doctor’ comes from the Greek ‘to teach.’ In this book Feinman leads us down a simple, logical, irrefutable path to the cause of many diseases affecting Westerners. He details the dishonest and fraudulent misinterpretation of science promulgated by Big Pharma and designed to mislead us toward prescription drug dependence. This represents unsustainable medicine for big profit. And yes, this is killing people. Making the lifestyle and nutritional changes necessary for lasting health is difficult. This book supplies the intellectual imperative to take control of your own health without resorting to symptom-suppressing medication. Read it, learn what you need to do, and you will be mentally empowered and physically fortified for life!”—Dr. Sarah Myhill, author of Sustainable Medicine and Diagnosis and Treatment of Chronic Fatigue Syndrome and Myalgic Encephalitis“Dr. Feinman has spent his professional life dedicated to exposing the many flaws found in most reporting in nutrition science. Nutrition in Crisis walks the reader through the fog of dubious statistical analysis and into the light of day. In doing so Dr. Feinman examines the science behind the low-carb debate, using humor and metaphor to engage the reader in the process.”—Miriam Kalamian, EdM, MS, CNS, author of Keto for Cancer“I’ve had the honor and privilege of knowing and working with Dr. Feinman for many years. I’ve watched him employ his deep knowledge of biochemistry and metabolism to tackle the entrenched, misguided nutritional advice cemented by thirty-five years of the food pyramid. His book says it all.”—Eugene Fine, professor, Department of Radiology, Albert Einstein College of Medicine“A distinctively insightful treatise on the sad state of affairs in nutrition written by one of the true thought leaders. In his unique Brooklyn style, teacher and intellectual Dr. Richard Feinman fights against ignorance by enlightening people on the real science and application of nutrition.”—Jeff S. Volek, professor, Department of Human Sciences, Ohio State University“Low-carb? Low-fat? Count your calories? If you have whiplash from trying to follow contradictory health headlines, you’re not alone. We’ve gotten ourselves into quite a nutritional mess thanks to poorly done research that was even more poorly reported to the public. With his trademark wry humor, Dr. Feinman exposes just how shoddy much of the research has been and outlines how to take control of your own health.”—Amy Berger, MS, CNS, NTP, author of The Alzheimer’s Antidote“I was first drawn to Professor Feinman through his prolific peer reviewed publications in nutrition and metabolism. He has been a leading pioneer in educating the academic community and lay public on the health benefits of low-carbohydrate and ketogenic diets. His work was a guiding light that inspired our lab to shift focus from drug-based research to metabolic-based therapies for neurological disorders and cancer. In addition to being a fantastic comprehensive review of practical nutritional biochemistry, this book tells an informative and entertaining story about what went wrong in the nutrition establishment and advocates for a rational solution to the problem.”—Dominic D’Agostino, PhD, leading scientist on ketogenic metabolic therapies“I have devoted my medical career to normalizing blood sugars in people with diabetes. This is only possible with very low carbohydrate diets. Dr. Feinman explains why low-carb is wise even for people without diabetes. This can’t-put-it-down title is the closest thing to a complete, popular analysis of the biochemistry of human nutrition that you will find and a superb lesson in how scientific studies have been manipulated to prove fiction.”—Richard K. Bernstein, MD, FACN, FACE, CWS, author of Dr. Bernstein’s Diabetes Solution and The Diabetes Diet“As a physician who has worked with thousands of patients unraveling the mysteries and mythology around diet and nutrition, it is refreshing and timely to come across a sane voice among the misinformation perpetuated by a misaligned food industry. We have moved far beyond the simple ‘calorie in, calorie out’ mentality and can now embrace biochemical individuality and updated research while avoiding the dogma of certain dietary camps.”—Nasha Winters, ND, FABNO, author of The Metabolic Approach to Cancer“Every scientific discipline needs a Dr. Richard David Feinman. He is just as skeptical about what he believes as what he disbelieves. His writing bears eloquent testimony to why he is such a scientific treasure.”—Timothy Noakes, MD, PhD, emeritus professor, University of Cape Town; founder, The Noakes Foundation“We have arrived at the most important nutritional crossroads in all of human history: We must choose to either keep the dietary status quo despite every bit of evidence that it has failed, or demand a change in order to salvage what is left of our collective health. In Nutrition in Crisis, Dr. Richard Feinman has dropped the opening salvo in what is sure to be a battle for the ages—one that determines the future of how we eat and the prevalence of disease in the years to come. Join the revolution!”—Jimmy Moore, health podcaster; bestselling author of Keto Clarity“With his usual cutting wit and verve, Dr. Feinman hacks through the tangled thicket of nutritional science to show us how we got to the sorry state we find ourselves in today. Obesity is at an all-time high, and diabetes has soared to epidemic proportions, yet the nutritional establishment, blind to its failures, continues to exhort us to trudge down the same path that got us to this pitiful mess in the first place. Dr. Feinman teaches us how to escape. He deploys his vast experience in biochemistry, nutrition, and the turgid mindset of academia to demystify mainstream nutritional research and explain how it has currently gone off the rails. With a sprinkling of humor and literary allusions, along with a deep dive into some of the nutritional literature, he tells readers what they need to know to shed excess body fat, lower blood sugar, and restore their health. A must read for anyone with a serious interest in health and nutrition.”—Michael R. Eades, MD, author of Protein Power“Fascinating book, full of original, interesting material by one of the original low-carb researchers whose grounding in the field goes back decades. Feinman combines a unique perspective with the experienced eye of a scientist. He’s had a front row seat to developments in the field of carbohydrates and metabolism over the past decades, which has given him key insights into the latest research.”—Nina Teicholz, author of The Big Fat Surprise
£17.99
Nova Science Publishers Inc Insulin Resistance: Symptoms, Causes & Treatment
Book SynopsisInsulin resistance (IR) and elevated blood pressure are two key features of the metabolic syndrome, which play an important role in the development of secondary cardiovascular complications. In this book, the effects of insulin resistance on the various vasoactive pathways are explored, which affect the equilibrium between vascular relaxation and constriction. Furthermore, the interaction between oestrogen, testosterone and insulin signalling-dependent changes in vascular reactivity and blood pressure are discussed. Also addressed in this book are the mechanisms underlying reciprocal relationships between insulin secretion, insulin resistance and inflammation in the pathological state and in its subsequent improvement. Moreover, the current concepts in understanding the underlying risk factors contributing to insulin resistance are examined, focusing on the role of magnesium deficiency that emerges as potential pathogenic key related with decreasing insulin sensitivity. In addition, it is widely accepted that metabolic syndrome is related to cardiovascular disease and that insulin resistance is one of the causes of metabolic syndrome. The authors discuss thiazolidinediones (TZDs), a class of antidiabetes agents, as a means to improve endothelial dysfunction, prevent atherosclerosis, and significantly reduce the risk of cardiovascular disease.
£185.99
Nova Science Publishers Inc Neurochemistry of Metabolic Diseases: Lysosomal
Book Synopsis
£146.24
Nova Science Publishers Inc Vitamin D: Biochemistry, Nutrition & Roles
Book Synopsis
£92.99
Nova Science Publishers Inc Computational Metabolomics
Book Synopsis
£63.74
Nova Science Publishers Inc Advances in Diagnosis & Management of
Book SynopsisThe literature concerning muscle Glycogenoses reflects a world-wide interest which has been greatly intensified, mainly over the last ten years. To a large extent, this renewed interest is due to recent advances in diagnosing and treating the Lysosomal disease named Glycogenosis II or Pompe disease (GSD II). The new therapeutic approaches must induce us to make a great effort in order to better diagnose, treat and follow correctly the patients with Pompe disease. This book is a comprehensive text which covers all of the aspects regarding this disease, from pathogenic to clinical and therapeutic features.
£106.49
Nova Science Publishers Inc Parathyroid: Anatomy, Functions & Disorders
Book SynopsisThis book follows an up to date authoritative style on the subject of parathyroid glands and their disorder. This book seeks to expand the horizon of parathyroid hormone use and provides in depth information on surgical techniques for managing its disorder. There are four sections on anatomy, function, disorder and treatment. The first three show how these areas are interconnected and the fourth on techniques for managing parathyroid disease. While short enough to be read as a treatise on parathyroid glands it is also authoritative enough to be used as a reference text.
£149.99
Nova Science Publishers Inc Advances in Diagnosis & Management of
Book SynopsisThe literature concerning muscle Glycogenoses reflects a world-wide interest which has been greatly intensified, mainly over the last ten years. To a large extent, this renewed interest is due to recent advances in diagnosing and treating the Lysosomal disease named Glycogenosis II or Pompe disease (GSD II). The new therapeutic approaches must induce us to make a great effort in order to better diagnose, treat and follow correctly the patients with Pompe disease. This book is a comprehensive text which covers all of the aspects regarding this disease, from pathogenic to clinical and therapeutic features.
£63.74
Nova Science Publishers Inc Glucose Uptake: Regulation, Signaling Pathways &
Book SynopsisInsulin stimulates the uptake of glucose in several target tissues, including skeletal muscle and adipose tissue, thereby contributing to the decline in the blood glucose level. In this book, the authors present current research in the study of the regulation, signalling pathways and health implications of glucose uptake. Topics include glucose uptake and transport regulation; the mechanisms that contribute to glucose homeostasis; expression and regulation of neuronal glucose transporters in health and disease; role for the microvasculature in glucose uptake in skeletal muscle; implications of diabetes on sperm glucose uptake and metabolism; the beneficial role of estrogen signalling in glucose homeostasis and energy expenditure; glucose uptake and androgen responsiveness of prostate cancer cells; regulation of intestinal glucose uptake by leptin; and the Ras superfamily of small GTP-binding proteins in glucose transporter type 4-mediated glucose uptake in insulin-responsive tissues.
£159.74
Thieme Medical Publishers Inc Lymphedema Management: The Comprehensive Guide
Book SynopsisFIVE STARS from Doody's Star Ratings™ This essential guide encompasses the core principles of Manual Lymph Drainage and Complete Decongestive Therapy for a wide range of pathologies across the age continuum. Key elements from the prior edition are incorporated, such as color-coded sections for anatomy, physiology, and pathophysiology. Advances in the field are reflected in expanded chapters and efficacy meta-analyses, updates on genetics, refinements in manual compression, and new insights on fat disorders and edema. Key highlights in fourth edition More than 140 new color images, over 30 new tables, and updated ICD-10 codes Expanded discussion of lipedema and related conditions such as Dercum's and Madelung's diseases Surgical approaches such as vascularized lymph node transfer, anastomosis and bypass techniques, suction assisted protein lipectomy, and combined and staged lymphedema operations Wound care options for edema and advanced venous disease Integration of conventional therapies and techniques in collaboration with surgeons who perform specialized lymphatic procedures Tips and guidance for growing numbers of home care focused practitioners who encounter lymphedema and related edemas in patients Management of garments including fit, functionality, and patient independence Rare pediatric syndromes and adaption of CDT for children Expanded discussion of sequential intermittent pneumatic compression including contraindications and usages in lymphedema management This is a must-have resource on the diagnosis, treatment, and management of lymphedema and lymphatic insufficiency. Its unique practicality will enable educators to teach techniques and clinicians to adeptly incorporate a wide range of treatment strategies into practice.Table of Contents1 Anatomy 2 Physiology 3 Pathology 4 Complete Decongestive Therapy 5 Treatment 6 Administration
£68.88
Healthy Lifestyles Hypothyroidism Diet [Second Edition]: Recipes for Hypothyroidism and Losing Weight Fast
£8.16
Hayle Medical Research Highlights on Prolactin
£71.24
Hayle Medical Diabetes: From Basic Science to Clinical Practice
Book Synopsis
£85.50
American Medical Publishers Advances in Endocrinology
Book Synopsis
£114.34
American Medical Publishers Clinical Neuroendocrinology
Book Synopsis
£99.10
American Medical Publishers Diabetes and Hyperglycemia: A Clinician's Guide
Book Synopsis
£107.41
American Medical Publishers Diabetes: Current Research
Book Synopsis
£110.18
American Medical Publishers Diabetic Nephropathy: Pathophysiology and
Book Synopsis
£113.65
American Medical Publishers Diagnosis and Treatment of Diabetes and Its
Book Synopsis
£114.34
American Medical Publishers Endocrine Disorders: Diagnosis and Management
Book Synopsis
£113.64
American Medical Publishers Gestational Diabetes: Causes, Diagnosis and
Book Synopsis
£107.41
American Medical Publishers Handbook of Diabetes
Book Synopsis
£110.88
American Medical Publishers Inborn Metabolic Diseases: A Clinical Approach
Book Synopsis
£113.65
American Medical Publishers Inborn Metabolic Diseases: Diagnosis and
Book Synopsis
£115.03
American Medical Publishers Thyroid Disease: Clinical Diagnosis and Therapy
Book Synopsis
£96.32
American Medical Publishers Thyroid Disease: Pathophysiology, Diagnosis and
Book Synopsis
£112.96